Viral encephalitis has a reported incidence of 1.2-4% in prospective evaluations of allo-SCT patients. Presenting symptoms most often include altered mental status, fever and seizures, and about half of the patients will have an abnormality on neuroimaging. Unfortunately, mortality rates for allo-SCT patients with viral encephalitis can be up to 80%.
/kg. The initial course was complicated by moderate venoocclusive disease with a peak bilirubin of 137 mmol/L.
After 48 h of insomnia, the patient developed increased irritability and visual hallucinations on day 19 that resolved with sleep. Brain magnetic resonance imaging performed on day 21 was normal, and his mental status was at baseline. On day 24, the patient had an intense 7-h episode of generalized pruritus without associated cutaneous findings. The pruritus was so severe that the patient created excoriations with his aggressive scratching. Multiple medications were tried to alleviate the pruritus and calm the patient including diphenhydramine, hydroxyzine, aprepitant, lorazepam, haloperidol, droperidol, quetiapine, olanzapine, gabapentin, zolpidem and ramelteon. Additional protective measures including mittens and restraint with a Posey vest were required. He also had hypothermia with an oral temperature range of 32.9-34.3 1C. Broadspectrum antibiotics were initiated and blood cultures remained negative. Thyroid function testing was normal.
Cerebrospinal fluid examination on day 25 was normal with WBC 1/mL, RBC 0/mL, glucose 6.4 mmol/L and protein 0.42 g/L. Cerebrospinal fluid testing included bacterial culture; PCR testing for adenovirus, CMV, HSV 1 and 2, HHV-6, Jakob-Creutzfeldt, VZV; and arbovirus titers. Electroencephalogram was normal. Neurological examination revealed a positional tremor of his upper extremities attributed to CYA, but was otherwise unremarkable. On day 27, the patient had another 7-h episode of unremitting pruritus with aggressive scratching requiring multiple medications including quetiapine. This episode was also characterized by hypothermia with an oral temperature range of 32.8-33.6 1C. On day 28, cerebrospinal fluid results returned detecting HHV-6 viral DNA by PCR. HHV-6 viral DNA was also detected in the plasma. Foscarnet (60 mg/kg/dose every 8 h) was initiated to treat the encephalitis and was dose adjusted on day 11 of the 21-day treatment course (45 mg/kg/dose every 8 h) for renal insufficiency. The patient experienced one more severe episode of generalized pruritus on day 35 for 5 h, again with associated hypothermia with an oral temperature range of 32.5-35.3 1C. In between each episode of severe pruritus, the patient was at his baseline mental status and normothermic. He never experienced amnesia or hyponatremia. Repeat plasma and cerebrospinal fluid testing at the end of the course of foscarnet did not detect HHV-6 viral DNA. Whole-blood testing for HHV-6 DNA was not obtained. The lack of persistently positive tests for HHV-6 and that the initial positive tests occurred three weeks before engraftment support an initial active infection rather than chromosomal integration of HHV-6.
The patient attained neutrophil engraftment at day 42. Additional complications included renal insufficiency, Klebsiella pneumonia bacteremia on day 47, and grade 4 BK hemorrhagic cystitis on day 54 treated with ciprofloxacin, continuous bladder irrigation by suprapubic tube and hyperbaric oxygen therapy. The patient is now 1-year post-transplant and has returned to school. He continues with moderate renal insufficiency and is treated with mirtazapine for depression and anxiety.
HHV-6 is a b-herpesvirus with variants HHV-6A and HHV-6B primarily associated with roseola infantum and febrile seizures. Over 90% of the population is infected within the first 18 months of life. After primary infection, HHV-6 persists in the host and is detectable in multiple tissues, similar to other herpesviruses. 3 In immunocompromised hosts, HHV-6 is associated with a broad spectrum of disease including interstitial pneumonitis, BM suppression and encephalitis. 4 HHV-6 has known tropism for CD4 T lymphocytes and BM progenitor cells in addition to neurotropism for astrocytes and neuronal cells. 4, 5 In the largest prospective series of viral encephalitis in allo-HSCT patients, HHV-6 was the most commonly detected virus. 6 Umbilical cord blood transplantation has been identified as a particular risk factor for HHV-6 encephalitis. 6, 7 Median onset of disease has been reported as relatively early post-transplant, at 23 and 62 days. 1, 6 Along with seizures and significant mental-status changes, pruritus has been reported in three encephalitis cases in pediatric umbilical cord blood transplant recipients.
A recent series described four adult umbilical cord blood transplant recipients who presented only with pruritus and dyesthesia. 6 Hypothermia, however, has not been previously reported in conjunction with HHV-6 encephalitis. On the contrary, fever was a presenting symptom in almost 75% of the patients infected with HHV-6 in the largest prospective series of viral encephalitis in allo-HSCT patients. 1 Pruritus after HSCT is typically associated with cutaneous findings such as GVHD, and the generation of the itch sensation occurs in the skin itself. Conversely, neurogenic pruritus occurs from the generation of the itch sensation in the central nervous system without primary cutaneous findings. 9 C-fibers are non-myelinated, smalldiameter primary afferent nerve fibers that include ultraslow histamine selective fibers responsible for itch, as well as warming specific receptors. Ad fibers are also small diameter fibers that include cooling-specific thermoreceptors. All of these fibers synapse with lamina I neurons in the substantia gelatinosa of the dorsal horn of the spinal cord. These neurons then project through the spinothalamic tract to the thalamus. 10 Given the constellation of symptoms in our patient, we hypothesize that our patient had primary involvement of the thalamus.
Outside of the well-recognized opiod-induced neurogenic pruritus, pruritus without primary cutaneous findings can present a diagnostic challenge in the HSCT patient. Pruritus without primary cutaneous findings, as well as hypothermia, should prompt a consideration of HHV-6 encephalitis.
